Suppr超能文献

高静水压辅助蛋白酶水解发酵海鲈副产物水解物中胆固醇微胶粒形成抑制肽的纯化与鉴定

Purification and Identification of Cholesterol Micelle Formation Inhibitory Peptides of Hydrolysate from High Hydrostatic Pressure-Assisted Protease Hydrolysis of Fermented Seabass Byproduct.

作者信息

Chen Guan-Wen, Lin Hong-Ting Victor, Huang Li-Wen, Lin Chia-Hua, Lin Yu-Hsin

机构信息

Department of Food Science, National Taiwan Ocean University, No. 2 Pei-Ning Road, Keelung 202, Taiwan.

Department of Biotechnology, National Formosa University, No. 64, Wunhua Rd, Yunlin 632, Taiwan.

出版信息

Int J Mol Sci. 2021 May 18;22(10):5295. doi: 10.3390/ijms22105295.

Abstract

This research focuses on the proteolytic capacity of sea bass byproduct (SB) and their hypocholesterolemic activity via the cholesterol micelle formation (CMF) inhibition. SB was fermented with seven mixed lactic acid bacteria for 5 h at 42 °C. The lactic fermented SB was hydrolyzed with Protease N for 6 h under HHP to obtain the SB hydrolysates (HHP-assisted Protease N hydrolysis after fermentation, F-HHP-PN6). The supernatant was separated from the SB hydrolysate and freeze-dried. As the hydrolysis time extended to 6 h, soluble protein content increased from 187.1 to 565.8 mg/g, and peptide content increased from 112.8 to 421.9 mg/g, while inhibition of CMF increased from 75.0% to 88.4%. Decreasing the CMF inhibitory activity from 88.4% to 42.1% by simulated gastrointestinal digestion (FHHP-PN6 was further hydrolyzed by gastrointestinal enzymes, F-HHP-PN6-PP) reduced the CMF inhibitory activity of F-HHP-PN6. Using gel filtration chromatography, the F-HHP-PN6-PP was fractioned into six fractions. The molecular weight of the fifth fraction from F-HHP-PN6-PP was between 340 and 290 Da, and the highest inhibitory efficiency ratio (IER) on CMF was 238.9%/mg/mL. Further purification and identification of new peptides with CMF inhibitory activity presented the peptide sequences in Ser-Ala-Gln, Pro-Trp, and Val-Gly-Gly-Thr; the IERs were 361.7, 3230.0, and 302.9%/mg/mL, respectively.

摘要

本研究聚焦于海鲈副产物(SB)的蛋白水解能力及其通过抑制胆固醇微胶粒形成(CMF)产生的降胆固醇活性。将SB与七种混合乳酸菌在42℃下发酵5小时。发酵后的SB在高压处理(HHP)下用蛋白酶N水解6小时,以获得SB水解产物(发酵后HHP辅助蛋白酶N水解,F-HHP-PN6)。从SB水解产物中分离出上清液并冻干。随着水解时间延长至6小时,可溶性蛋白含量从187.1毫克/克增加到565.8毫克/克,肽含量从112.8毫克/克增加到421.9毫克/克,而CMF抑制率从75.0%增加到88.4%。通过模拟胃肠道消化将CMF抑制活性从88.4%降低到42.1%(F-HHP-PN6进一步经胃肠道酶水解,F-HHP-PN6-PP),降低了F-HHP-PN6的CMF抑制活性。使用凝胶过滤色谱法,将F-HHP-PN6-PP分离成六个组分。F-HHP-PN6-PP的第五个组分的分子量在340至290道尔顿之间,对CMF的最高抑制效率比(IER)为238.9%/毫克/毫升。对具有CMF抑制活性的新肽进行进一步纯化和鉴定,得到了Ser-Ala-Gln、Pro-Trp和Val-Gly-Gly-Thr的肽序列;IER分别为361.7、3230.0和302.9%/毫克/毫升。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaf4/8157361/c07109a3187d/ijms-22-05295-g0A1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验